BioCentury
ARTICLE | Clinical News

Cis-UCA Eye Drops: Completed Phase II enrollment

April 6, 2015 7:00 AM UTC

Herantis completed enrollment of 161 patients in a double-blind, placebo-controlled, U.S. Phase II trial evaluating 1% and 2.5% cis-UCA Eye Drops for 4 weeks. ...